Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth F Koral

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|April 2, 2004
Scatter modelling and compensation in emission tomographyHabib Zaidi, Kenneth F Koral
Physics in Medicine and Biology|January 18, 2007
Recovery of total I-131 activity within focal volumes using SPECT and 3D OSEMKenneth F Koral, Anastasia Yendiki, Yuni K Dewaraja
Physics in Medicine and Biology|April 16, 2010
Regularized reconstruction in quantitative SPECT using CT side information from hybrid imagingYuni K Dewaraja, Kenneth F Koral, Jeffrey A Fessler
Computer Methods and Programs in Biomedicine|January 26, 2002
A parallel Monte Carlo code for planar and SPECT imaging: implementation, verification and applications in (131)I SPECTYuni K Dewaraja, Michael Ljungberg, Amitava Majumdar, et al.
AJR. American Journal of Roentgenology|August 24, 2010
Staging of differentiated thyroid carcinoma using diagnostic 131I SPECT/CTKa Kit Wong, James C Sisson, Kenneth F Koral, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 6, 2012
Prediction of therapy tumor-absorbed dose estimates in I-131 radioimmunotherapy using tracer data via a mixed-model fit to time activityMatthew J Schipper, Kenneth F Koral, Anca M Avram, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 22, 2009
Use of integrated SPECT/CT imaging for tumor dosimetry in I-131 radioimmunotherapy: a pilot patient studyYuni K Dewaraja, Scott J Wilderman, Kenneth F Koral, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2005
Accurate dosimetry in 131I radionuclide therapy using patient-specific, 3-dimensional methods for SPECT reconstruction and absorbed dose calculationYuni K Dewaraja, Scott J Wilderman, Michael Ljungberg, et al.
Cancer|March 6, 2002
Volume reduction versus radiation dose for tumors in previously untreated lymphoma patients who received iodine-131 tositumomab therapy. Conjugate views compared with a hybrid methodKenneth F Koral, Isaac R Francis, Stewart Kroll, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 7, 2008
Hepatic absorbed radiation dosimetry during I-131 metaiodobenzylguanidine (MIBG) therapy for refractory neuroblastomaKenneth F Koral, John P Huberty, Bill Frame, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
European Journal of Nuclear Medicine and Molecular Imaging|April 2, 2004
Scatter modelling and compensation in emission tomographyHabib Zaidi, Kenneth F Koral
Physics in Medicine and Biology|January 18, 2007
Recovery of total I-131 activity within focal volumes using SPECT and 3D OSEMKenneth F Koral, Anastasia Yendiki, Yuni K Dewaraja
Physics in Medicine and Biology|April 16, 2010
Regularized reconstruction in quantitative SPECT using CT side information from hybrid imagingYuni K Dewaraja, Kenneth F Koral, Jeffrey A Fessler
Computer Methods and Programs in Biomedicine|January 26, 2002
A parallel Monte Carlo code for planar and SPECT imaging: implementation, verification and applications in (131)I SPECTYuni K Dewaraja, Michael Ljungberg, Amitava Majumdar, et al.
AJR. American Journal of Roentgenology|August 24, 2010
Staging of differentiated thyroid carcinoma using diagnostic 131I SPECT/CTKa Kit Wong, James C Sisson, Kenneth F Koral, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 6, 2012
Prediction of therapy tumor-absorbed dose estimates in I-131 radioimmunotherapy using tracer data via a mixed-model fit to time activityMatthew J Schipper, Kenneth F Koral, Anca M Avram, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 22, 2009
Use of integrated SPECT/CT imaging for tumor dosimetry in I-131 radioimmunotherapy: a pilot patient studyYuni K Dewaraja, Scott J Wilderman, Kenneth F Koral, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2005
Accurate dosimetry in 131I radionuclide therapy using patient-specific, 3-dimensional methods for SPECT reconstruction and absorbed dose calculationYuni K Dewaraja, Scott J Wilderman, Michael Ljungberg, et al.
Cancer|March 6, 2002
Volume reduction versus radiation dose for tumors in previously untreated lymphoma patients who received iodine-131 tositumomab therapy. Conjugate views compared with a hybrid methodKenneth F Koral, Isaac R Francis, Stewart Kroll, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 7, 2008
Hepatic absorbed radiation dosimetry during I-131 metaiodobenzylguanidine (MIBG) therapy for refractory neuroblastomaKenneth F Koral, John P Huberty, Bill Frame, et al.
Pageof 2